Generics exceed branded drugs sales in Bulgaria
This article was originally published in Scrip
Sales of generic drugs in Bulgaria stood at €459 million last year, exceeding those of branded products (€357 million) by almost 30%. The volume of generic drugs sold was more than five times higher than branded medicines (210 million and 40 million packs, respectively). The average price of a branded medicine pack was €9 compared with €2 for a generic product.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.